FRANCINE KAMHOUA: Open Payments
NPI 1275145468 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$164 in 6 payments from 6 companies in 2025. Trend: 2023 $351 · 2024 $47 · 2025 $164
Food & beverage: $164
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $40 |
| Lundbeck LLC | 1 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: REXULTI, INVEGA SUSTENNA, INGREZZA, COBENFY, Auvelity.
Industry payments across MD — which companies pay providers there.
